Search results
Despite its 'nothingburger' reputation, COVID-19 remains deadlier than the flu
LA Times via Yahoo News· 2 days agoThe COVID-19 patients were a little older, on average, than the flu patients (73.9 versus 70.2 years...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 4 days agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...
Salem CVS fined $75K after 17-year-old given 6 COVID-19 vaccine doses, drug theft: Report
ABC 13 Lynchburg· 20 hours agoCVS/Pharmacy #3794, located at 11 Chestnut Street, was ordered to pay $75,000 for violations,...
Moderna wins patent case in Europe against Pfizer, BioNTech over COVID shot
Reuters· 2 hours agoModerna said that the European Patent Office had decided to maintain the validity of one of the...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British ...
As states loosen childhood vaccine requirements, health experts’ worries grow
Florida Phoenix via Yahoo News· 8 hours agoKathy Edmonston believes no one ought to be required to vaccinate their children. So, she wants...
As states loosen childhood vaccine requirements, health experts’ worries grow
Tennessee Lookout via Yahoo News· 9 hours agoKathy Edmonston believes no one ought to be required to vaccinate their children. So, she wants...
Mom suffers ‘disabling pain’ after COVID shot trial, suit says. She’s suing AstraZeneca
Miami Herald via Yahoo News· 3 days agoA Utah mother is suing AstraZeneca after she participated in a clinical trial for the company’s ...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British ...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi
Investing.com· 6 days agoNovavax retains its pipeline rights and could earn substantial royalties from Sanofi's development...